Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page
- Check4 days agoChange DetectedVersion bump to v3.0.2 from v3.0.1; no core content or data changes detected. The removal of 'Back to Top' is a minor UI adjustment.SummaryDifference0.2%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check18 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific medical terms and location details have been removed.SummaryDifference0.9%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.